HIV and AIDS Trial, Recruiting NCT06158607 Sponsor: The University of Texas Health Science Center, Houston Condition: HIV and AIDS
Back to Hiv Aids

HIV and AIDS Trial, Recruiting

NCT06158607
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • Black/African American and Hispanic/Latina cisgender women
  • People diagnosed with a substance use disorder (a condition where use of alcohol or drugs causes significant problems in a person's life), based on standard medical guidelines (DSM-5)
  • People who have tested negative for HIV
  • People who have been sexually active with a male partner in the past 6 months
  • People who are not currently using PrEP (a medication taken to prevent HIV) at the time of screening
  • People who are able to speak, read, and write in English
  • People who own or regularly have access to a smartphone

Who may not be able to join:

  • People who are currently taking part in another treatment program for substance use disorders
  • People who are not able to give informed consent — for example, due to severe difficulties with thinking or understanding that would affect their ability to agree to participate, follow study procedures, or take part in therapy
  • People experiencing a level of psychological distress that would prevent them from taking part in the study
  • People who are unable or unwilling to meet the study's requirements
  • People who do not meet the CDC's (Centers for Disease Control and Prevention) guidelines for PrEP eligibility based on their substance use and sexual risk factors (confirm with trial site)
  • People who have a medical reason why PrEP would not be safe for them — for example, known kidney problems that could be made worse by PrEP

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 8 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Angela Heads, PhD, The University of Texas Health Science Center, Houston

Phone: (713) 486-2830

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Registry
ClinicalTrials.gov
Start date
7 June 2022
Est. completion
30 May 2025

Where this trial is recruiting

🇺🇸 United States

Primary endpoints

PrEP uptake

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 8 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov